Recombinant Staphylococcus saprophyticus subsp. saprophyticus UPF0344 protein SSP1805 (SSP1805)

What is UPF0344 protein SSP1805 and why is it classified as a hypothetical protein?

The UPF0344 protein SSP1805 is a protein from Staphylococcus saprophyticus subsp. saprophyticus that belongs to the UPF0344 protein family . It is classified as a hypothetical protein because its function has not been experimentally determined or verified, despite its sequence being identified through genomic sequencing. The protein is encoded by either the SSP1805 gene or alternatively designated as SSP_RS09070 in some genomic annotations . The classification as "hypothetical" indicates that while the open reading frame exists in the genome and is predicted to be expressed, the biological role of the resulting protein remains uncharacterized. Researchers studying hypothetical proteins typically employ a combination of bioinformatic analyses, structural predictions, and experimental approaches to elucidate their functions.

What expression systems are available for recombinant SSP1805 protein production?

Multiple expression systems are available for the recombinant production of SSP1805 protein, each offering distinct advantages for different research applications. These include:

• Cell-free expression systems - Allow for rapid protein production without the constraints of cell viability, particularly useful for potentially toxic proteins .

• E. coli-based expression - The most commonly used system, offering high yields and cost-effectiveness for basic structural and functional studies .

• Yeast expression systems - Provide eukaryotic post-translational modifications while maintaining relatively high protein yields .

• Baculovirus-infected insect cells - Offer complex eukaryotic protein processing capabilities suitable for proteins requiring specific modifications .

• Mammalian cell expression - Provides the most sophisticated post-translational modification machinery, ideal for studying proteins in a context closer to higher organisms .

The selection of an expression system should be based on specific research objectives, required protein yield, post-translational modification needs, and downstream applications.

How should researchers validate the identity and quality of purified recombinant SSP1805?

Validation of recombinant SSP1805 should follow a multi-technique approach to ensure both identity and quality. Standard validation protocols include:

• SDS-PAGE analysis to assess purity (target ≥85%) and apparent molecular weight .

• Western blotting with antibodies against either the target protein or affinity tags.

• Mass spectrometry (MS) for accurate molecular weight determination and peptide mapping.

• Circular dichroism (CD) spectroscopy to verify proper protein folding.

• Dynamic light scattering (DLS) to assess protein homogeneity and aggregation state.

A comprehensive validation table should include:

Validation data should be thoroughly documented to ensure reproducibility across experiments and between different batches of the recombinant protein.

How might SSP1805 relate to S. saprophyticus virulence mechanisms?

To understand the potential role of SSP1805 in S. saprophyticus virulence, researchers must consider the broader context of this pathogen's virulence mechanisms. S. saprophyticus is known to cause urinary tract infections (UTIs) through several virulence factors, including urease, surface proteins, and D-serine-deaminase protein (DsdA) . Although SSP1805 is currently classified as a hypothetical protein, several experimental approaches can help determine its potential role in virulence:

• Comparative proteomics between virulent strains (like 9325) and less virulent strains to assess SSP1805 expression levels .

• Interaction studies with known virulence factors or regulatory systems.

• Knockout or knockdown studies to observe phenotypic changes in virulence-associated behaviors.

• Host-pathogen interaction assays comparing wild-type and SSP1805-deficient strains.

Research on S. saprophyticus has demonstrated significant proteomic flexibility among different strains, which correlates with differences in virulence and persistence capabilities . If SSP1805 shows differential expression patterns between strains with varying virulence (such as strains 9325, 7108, and ATCC 15305), this could suggest a potential role in pathogenicity.

What methodologies are most appropriate for determining protein-protein interactions involving SSP1805?

Elucidating the protein-protein interactions of SSP1805 is crucial for understanding its biological function. Multiple complementary approaches should be employed:

• Affinity-based methods:

  • Co-immunoprecipitation (Co-IP) with tagged SSP1805

  • Pull-down assays with GST or His-tagged SSP1805

  • Proximity-dependent biotin identification (BioID)

• Biophysical techniques:

  • Surface plasmon resonance (SPR)

  • Isothermal titration calorimetry (ITC)

  • Microscale thermophoresis (MST)

• Crosslinking approaches:

  • Chemical crosslinking followed by MS (XL-MS)

  • Photo-affinity labeling

• Library screening methods:

  • Yeast two-hybrid (Y2H) screening

  • Bacterial two-hybrid screening

  • Phage display

For a comprehensive interaction study, researchers should develop a hierarchical workflow beginning with high-throughput screening methods followed by validation using multiple orthogonal techniques. This approach minimizes false positives while providing quantitative interaction parameters.

When publishing interaction data, tables should include the following:

How can researchers design experiments to determine if SSP1805 functions within a regulatory network?

Bacterial regulatory networks are complex and often involve two-component systems, transcription factors, and other regulatory elements. To determine if SSP1805 functions within such networks:

• Transcriptomic analysis:

  • RNA-seq comparing wild-type and SSP1805 knockout strains

  • qPCR validation of differentially expressed genes

• Chromatin immunoprecipitation (ChIP) approaches:

  • ChIP-seq to identify potential DNA binding if SSP1805 has DNA-binding domains

  • ChIP-qPCR for targeted analysis of specific promoter regions

• Reporter gene assays:

  • Construction of promoter-luciferase fusions for potential target genes

  • Analysis of expression in response to SSP1805 levels

• Gel-shift assays:

  • Electrophoretic mobility shift assays (EMSA) to detect direct DNA binding

  • Competition assays to determine binding specificity

A methodical approach would involve first identifying whether SSP1805 expression correlates with known regulatory systems in S. saprophyticus. For example, in S. aureus, regulatory proteins like SA1804 work in conjunction with two-component systems like SaeRS to regulate virulence factors . Similar regulatory relationships might exist for SSP1805 in S. saprophyticus.

What is the optimal experimental design for creating and validating an SSP1805 knockout strain?

Creating and validating an SSP1805 knockout strain requires a systematic approach to ensure the specificity of the genetic modification and proper phenotypic characterization:

• Knockout strategy selection:

  • Allelic replacement via homologous recombination

  • CRISPR-Cas9 genome editing

  • Transposon mutagenesis (less specific)

• Validation of genetic modification:

  • PCR verification of the modified genomic region

  • Whole-genome sequencing to confirm absence of off-target effects

  • RT-qPCR to confirm absence of SSP1805 transcript

  • Western blotting to confirm absence of SSP1805 protein

• Complementation studies:

  • Reintroduction of SSP1805 gene via plasmid expression

  • Verification of phenotype restoration

• Phenotypic characterization:

  • Growth curves under various conditions

  • Virulence assays (cell invasion, macrophage survival)

  • Biofilm formation capacity

  • Comparative proteomics

A validation table for the knockout strain should document:

How should researchers design experiments to investigate SSP1805's potential role in biofilm formation?

Given that S. saprophyticus strains show variable biofilm formation capabilities , investigating SSP1805's potential role in this process is scientifically relevant. A comprehensive experimental design would include:

• Comparative expression analysis:

  • qPCR measurement of SSP1805 expression in planktonic versus biofilm growth

  • Proteomic analysis of biofilm versus planktonic cells, focusing on SSP1805 abundance

• Phenotypic analysis of SSP1805 knockout:

  • Quantitative biofilm assays using crystal violet staining

  • Confocal laser scanning microscopy (CLSM) of biofilm architecture

  • Flow cell biofilm formation analysis

  • Measurement of extracellular polymeric substance (EPS) production

• Biofilm formation under varying conditions:

  • Nutrient limitation

  • Subinhibitory antibiotic concentrations

  • Environmental stressors (pH, temperature)

  • Host-relevant conditions (artificial urine medium)

• Molecular interactions within biofilms:

  • Co-immunoprecipitation to identify interaction partners in biofilm vs. planktonic states

  • Localization studies using fluorescently tagged SSP1805

Results should be presented in tables comparing the wild-type, knockout, and complemented strains:

What proteomic approaches can be used to study SSP1805 in the context of S. saprophyticus virulence?

Proteomic analysis provides valuable insights into the expression, localization, and interactions of proteins like SSP1805. For studying SSP1805 in the context of virulence, researchers should consider:

• Comparative proteomics:

  • Comparison between virulent and less virulent strains (e.g., 9325 vs. 7108)

  • Analysis of different growth conditions (planktonic, biofilm, host-mimicking)

  • Temporal analysis during infection process

• Subcellular fractionation:

  • Separate analysis of cytoplasmic, membrane, and secreted fractions

  • Localization of SSP1805 in different cellular compartments

• Post-translational modification (PTM) analysis:

  • Phosphoproteomics to detect phosphorylation events

  • Other PTM analyses as relevant (glycosylation, acetylation)

• Interaction proteomics:

  • Immunoprecipitation coupled with mass spectrometry (IP-MS)

  • Cross-linking MS for capturing transient interactions

  • Hydrogen-deuterium exchange MS for structural insights

An experimental design table should outline:

How should researchers interpret conflicting data regarding SSP1805 function across different experimental approaches?

Interpreting conflicting data is a common challenge in characterizing hypothetical proteins like SSP1805. A systematic approach includes:

• Critical evaluation of methodological differences:

  • Assess variations in experimental conditions, strain backgrounds, and reagents

  • Evaluate the sensitivity and specificity of each method

  • Consider biological versus technical replicates

• Hierarchical weighting of evidence:

  • In vivo studies generally provide more biologically relevant insights than in vitro studies

  • Direct biochemical evidence often outweighs correlative or computational predictions

  • Consider reproducibility across independent laboratories

• Integration of multiple data types:

  • Create data integration tables comparing results across methods

  • Develop consensus models that accommodate seemingly contradictory results

  • Consider that proteins often have multiple functions in different contexts

• Follow-up validation experiments:

  • Design experiments specifically to resolve contradictions

  • Use orthogonal approaches to verify key findings

  • Consider conditional or context-dependent effects

A data interpretation framework might look like:

What statistical approaches are most appropriate for analyzing SSP1805 knockout phenotype data?

• Experimental design considerations:

  • Power analysis to determine appropriate sample sizes

  • Inclusion of biological and technical replicates

  • Randomization and blinding where applicable

  • Appropriate controls (wild-type, complemented strain, empty vector)

• Statistical tests for different data types:

  • Continuous variables (growth rates, biofilm biomass): t-tests or ANOVA with post-hoc tests

  • Survival data: Kaplan-Meier analysis with log-rank tests

  • Count data: Chi-square or Fisher's exact tests

  • Non-normally distributed data: Non-parametric alternatives (Mann-Whitney, Kruskal-Wallis)

• Multiple testing corrections:

  • Bonferroni correction for conservative approach

  • False Discovery Rate (FDR) methods for large-scale data

  • Indication of exact p-values rather than thresholds (p<0.05)

• Data presentation guidelines:

  • Always include measures of central tendency with dispersion (mean ± standard deviation)

  • Include ranges for parameters like age and scores

  • Present both absolute numerical values and percentages

A statistical analysis plan should be documented as:

How can SSP1805 research contribute to understanding strain-specific differences in S. saprophyticus pathogenicity?

S. saprophyticus strains demonstrate significant phenotypic and proteomic differences that affect their virulence and persistence capabilities . Research on SSP1805 can provide valuable insights into these strain-specific differences through:

• Comparative genomic and expression analyses:

  • Examination of SSP1805 sequence variations across clinical isolates

  • Correlation of expression levels with virulence phenotypes

  • Identification of strain-specific regulatory mechanisms controlling SSP1805

• Functional studies across strain backgrounds:

  • Creation of SSP1805 knockouts in multiple strain backgrounds (e.g., ATCC 15305, 7108, 9325)

  • Comparison of phenotypic effects in different genetic backgrounds

  • Assessment of strain-specific interaction partners

• Host-pathogen interaction studies:

  • Evaluation of SSP1805 contribution to macrophage survival in different strains

  • Assessment of epithelial cell invasion capacity and the role of SSP1805

  • Host response to different strains with and without SSP1805

A strain comparison table might present:

What are the most promising future research directions for understanding SSP1805 function?

Based on current knowledge of S. saprophyticus and hypothetical proteins like SSP1805, several promising research directions emerge:

• Structural biology approaches:

  • X-ray crystallography or cryo-EM to determine SSP1805 structure

  • Structure-function analysis to identify active sites or interaction domains

  • Molecular dynamics simulations to predict functional properties

• Systems biology integration:

  • Multi-omics approaches combining transcriptomics, proteomics, and metabolomics

  • Network analysis to position SSP1805 within cellular pathways

  • Machine learning approaches to predict function from diverse data types

• Host-pathogen interaction focus:

  • Investigation of SSP1805's role during different stages of infection

  • Identification of host targets or immune responses to SSP1805

  • Development of cell and animal models to study SSP1805 in vivo

• Translational research potential:

  • Assessment of SSP1805 as a diagnostic biomarker for S. saprophyticus infections

  • Evaluation as a potential vaccine candidate if surface-exposed

  • Exploration as a drug target if essential for virulence

A research roadmap might be structured as: